Research only
All of alz.org
ALZ.ORG Research Center Alzheimer's Association International Conference ISTAART Journal Grants TrialMatch Press Donate Contact

Corporate Symposia - non-CME

Monday, July 15, 2013
12-2 p.m.
Broadening Horizons: Medical Nutrition for Managing Early Alzheimer’s disease

Synapse loss is an early event in Alzheimer's disease and it is the pathological hallmark that correlates best with memory performance. This symposium will examine the evidence for the specific nutritional requirements in AD and how Souvenaid can be a clinically viable option to help manage patients with early AD.

Location
Westin Hotel Waterfront, Grand Ballroom

Sponsorship
Nutricia


Monday, July 15, 2013
5:30-9 p.m.
Amyloid Imaging: Appropriateness and Challenges

The Appropriate Use Criteria for amyloid PET imaging have recently been published. The neuropathological evidence supporting the patient selection for the Appropriate Use Criteria and physician decision-making in light of limited treatment options will be discussed. Theoretical cases will be presented for discussion.

Location
Pacific Grand Ballroom, Renaissance Boston Waterfront Hotel

RSVP

Sponsorship
GE Healthcare


Monday, July 15, 2013
6 p.m.
Emerging Trends in AD Management: Introducing a New Treatment Option

This informative program will feature three expert speakers reviewing the safety and efficacy of a new treatment option for of moderate to severe Alzheimer’s disease, as well as recent updates and insights into disease-related developments.

Location
Westin Boston Waterfront Hotel, Grand Ballroom

RSVP

Sponsorship
Forest Pharmaceuticals


Tuesday, July 16, 2013      
6-7:30 p.m.
Exploring the Neurobiology of Alzheimer’s Disease From the Inside Out

Location
Grand Ballroom, Westin Waterfront Hotel

Sponsorship
Eli Lilly


Tuesday, July 16, 2013
6-7:30 p.m.
Considerations for Mild-to-Moderate Alzheimer’s Disease with Cholinesterase Inhibitor

In the absence of disease-modifying therapies for Alzheimer’s disease, there is a
need to optimize available symptomatic treatments. This symposium will explore
data from clinical trials and discuss considerations for managing patients with mild to
moderate Alzheimer’s disease using a cholinesterase inhibitor.

Location
Pacific Grand Ballroom, Renaissance Boston Waterfront Hotel

Sponsorship
Novartis


Where the world reveals the latest dementia research • Copenhagen, Denmark • July 12-17, 2014